The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Chunhui Xu and her team leveraged the ISS National Laboratory ® for cardiac cell research to accelerate the development of cell-based regenerative therapies that could one day reverse heart damage.